Old Web
English
Sign In
Acemap
>
authorDetail
>
Shohan Yanagi
Shohan Yanagi
Evolocumab
Hyperlipidemia
PCSK9
Biochemistry
Statin
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dinaphtho[2,1-b:1′,2′-d]thiophenes as High Refractive Index Materials Exploiting the Potential Characteristics of “Dynamic Thiahelicenes”
2021
Journal of Materials Chemistry C
Yoko Nambu
Yoko Yoshitake
Shohan Yanagi
Kenji Mineyama
Keisuke Tsurui
Shigeki Kuwata
Toshikazu Takata
Tadatomi Nishikubo
Ken Ishikawa
Show All
Source
Cite
Save
Citations (0)
The New Molecular Entity Evolocumab, One Kind of PCSK9 Inhibitor, Reduce Plasma Small Size LDL-Cholesterol Levels by Using a New Standardized Method of Measuring LDL Size
2017
Ikuo Inoue
Ryo Kubota
Shohan Yanagi
Masumi Akita
Takanari Nakano
Shigehiro Katayama
Akira Shimada
Mistuhiko Noda
Show All
Source
Cite
Save
Citations (2)
カーボンナノチューブ含有樹脂組成物、硬化物、成形体及びカーボンナノチューブ含有樹脂組成物の製造方法
2008
Takeshi Nakahara
Hiroshi Takami
Shohan Yanagi
takesi nakahara
syou bon yanagi
kou takami
Show All
Source
Cite
Save
Citations (0)
1